Labetalol (Trandate) . an antihypertensive agent with both alpha and beta receptor blockading effects
Rasmussen, S.; Andreasen, P.B.
Ugeskrift for Laeger 142(13): 839-841
1980
ISSN/ISBN: 0041-5782 PMID: 6102812 Document Number: 168309
Document emailed within 1 workday
Related Documents
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311Armah, B.I. 1988: Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine Arzneimittel-Forschung 38(10): 1435-1442
Kirch, W.; Von Gizycki, C. 1980: Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances International Journal of Clinical Pharmacology Therapy and Toxicology 18(5): 233-235
Musso, E.; Taccardi, B. 1970: Modifications of the electric activity of the guinea pig myocardial fiber induced by 4 stereoisomers of butidrine, a new compound with adrenergic beta receptor blockading action Archives Internationales de Pharmacodynamie et de Therapie 183(1): 173-189
Nakagawa, Y.; Takeda, K.; Sakurai, H.; Mitomi, A.; Imai, S. 1981: Antihypertensive effects of labetalol in three types of hypertensive models of rats Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 77(4): 435-445
Pacifici, R.; Roman, J.; Kimble, R.; Civitelli, R.; Brownfield, C.M.; Bizzarri, C. 1994: Ligand binding to monocyte alpha 5 beta 1 integrin activates the alpha 2 beta 1 receptor via the alpha 5 subunit cytoplasmic domain and protein kinase C Journal of Immunology 153(5): 2222-2233
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Jacob, B.G.; Richter, W.O.; Schwandt, P. 1993: Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators Fortschritte der Medizin 111(8): 126-129
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Novo, S.; Abrignani, M.G.; Sapienza, N.D.; Barbagallo, M.; Pinto, A.; Di Maria, G.U.; Mistretta, A.; Strano, A. 1992: Partial regression of vascular structural alterations in hypertensive patients treated with alpha-beta-blocker, labetalol International Angiology: a Journal of the International Union of Angiology 11(2): 137-141
Forette, F.; Henry-Amar, M.; d'Allens, H.; Hervy, M.P.; Bouchacourt, P.; Henry, J.F.; Pappo, M. 1987: Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol Annales de Cardiologie et d'Angeiologie 36(2): 103-107
Takahama, Y.; Kosugi, A.; Singer, A. 1991: Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage Journal of Immunology 146(4): 1134-1141
Schmidt-Wolf, I.G.; Liang, O.; Dejbakhsh-Jones, S.; Wang, H.; Cheng, L.; Holm, B.; Bell, R.; Strober, S. 1993: Homogeneous antigen receptor beta-chain genes in cloned CD4- CD8- alpha beta T suppressor cells Journal of Immunology 151(10): 5348-5353
Watkins, R.W.; Sybertz, E.J.; Cook, J.; Pula, K.; Cedeno, K.; Tedesco, R.P.; McLeod, R. 1989: Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol Archives Internationales de Pharmacodynamie et de Therapie 302: 158-173
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Hayashi, H.; Onozaki, K. 2005: Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 60-64
Hayashi, H.; Onozaki, K. 2010: Interleukin-1(IL-1) alpha, beta, IL-1 receptor (IL-1R), IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 62-66
Jacobsen, S.E.; Ruscetti, F.W.; Roberts, A.B.; Keller, J.R. 1993: TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3 Journal of Immunology 151(9): 4534-4544
Allione, A.; Wells, V.; Forni, G.; Mallucci, L.; Novelli, F. 1998: Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes Journal of Immunology 161(5): 2114-2119
Baum, T.; Watkins, R.W.; Sybertz, E.J.; Vemulapalli, S.; Pula, K.K.; Eynon, E.; Nelson, S.; Vliet, G.V.; Glennon, J.; Moran, R.M. 1981: Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol Journal of Pharmacology and Experimental Therapeutics 218(2): 444-452